Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medication...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glaukos Corporation
NCT07418853 · Open Angle Glaucoma (OAG), Primary Open Angle Glaucoma (POAG), and more
NCT06630546 · Primary Open Angle Glaucoma (POAG), Istent Inject W, and more
NCT02700984 · Primary Open Angle Glaucoma (POAG)
NCT01252849 · Primary Open Angle Glaucoma (POAG)
NCT01085357 · Primary Open Angle Glaucoma (POAG), Cataract
Department of Ophthalmology - UNIFESP/ Hospital São Paulo
São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions